Appropriateness of colonoscopy: Inflammatory bowel disease

Endoscopy

Volumn 31, Issue 8, 1999, Pages 647-653

  Froehlich, Florian ^a   Larequi Lauber, T ^b   Gonvers, J J ^a   Dubois, R W ^c   Burnand, B ^b   Vader, J P ^b  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Protocare Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONOSCOPY; CROHN DISEASE; DYSPLASIA; HUMAN; IRRITABLE COLON; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; UTILIZATION REVIEW;

COLITIS, ULCERATIVE; COLONOSCOPY; CROHN DISEASE; HUMANS;

EID: 0032589921     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-126     Document Type: Review

References (47)

1. Vader JP, Bumand B, Froehlich F, Dubois RW, Bochud M, Gonvers JJ. The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): Project and methods. Endoscopy 1999; 31: 572-578
2. Vader JP, Froehlich F, Dubois RW, Beglinger C, Wietlisbach V, Pittet V, Ebel N, Gonvers JJ, Burnand B. The European Panel on the Appropriateness of Gastrointestinal Endoscopy (EPAGE): Conclusions and WWW site. Endoscopy 1999; 31: 687-694
3. Rutgeerts P, Vantrappen G, Geboes K. Endoscopy in inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 12-15
4. Mantzaris GJ, Hatzis A, Archavlis E, Petraki K, Lazou A, Triantafyllou G, Raptis SA. The role of colonoscopy in the differential diagnosis of acute, severe hemorrhagic colitis. Endoscopy 1995; 27: 645-653
5. Schumacher G, Sandstedt B, Kollberg B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis - Clinical findings and early diagnosis. Scand J Gastroenterol 1994; 29: 265-274
6. Geboes K, Delabie J, Rutgeerts P, Vantrappen G. Endoscopy as a diagnostic tool in inflammatory bowel disease. Acta Chirurgica Belgica 1989; 89: 106-110
7. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991; 325: 928-937
8. Podolsky DK. Inflammatory bowel disease (2) (see comments). N Engl J Med 1991; 325: 1008-1016
9. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993; 38: 1137-1146
10. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-266
11. Carbonnel F, Lavergne A, Lemann M, Bitoun A, Valleur P, Hautefeuille P, Galian A, Modgliani R, Rambaud JC. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Digestive Diseases & Sciences 1994; 39: 1550-1557
12. Hanauer SB, Sninksy CA, Robinson M, Powers BY, McHattie JD, Mayle JE, Elson CO, DeMicco MP, Butt JH, Pruitt RE, et al. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. Ann Intern Med 1996; 124: 204-211
13. Courtney MG, Nunes DP, Bergin CF, O'Driscoll M, Trimble V, Keeling PW, Weir DG. Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet 1992; 339: 1279-1281
14. Landi B, Anh TN, Cortot A, Soule JC, Rene E, Gendre JP, Bories P, See A, Metman EH, Florent C, et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial: The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology 1992; 102: 1647-1653
15. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818-1825
16. Bo-Linn GW, Vendrell DD, Lee E, Fordtran JS. An evaluation of the significance of microscopic colitis in patients with chronic diarrhea. Journal of Clinical Investigation 1985; 75: 1559-1569
17. Rutgeerts P, Lofberg R, Malchow H, Lamers C, Olaison G, Jewell D, Danielsson A, Goebell H, Thomsen OO, Lorenz-Meyer H, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994; 331: 842-845
18. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Williams CN, Nilsson LG, Persson T. Oral budesonide for active Crohn's disease. Canadian inflammatory bowel disease study group. N Engl J Med 1994; 331: 836-841
19. Vasen HF, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, Offerhaus GJ, Meera Khan P. Hereditary non-polyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer 1995; 31: 1145-1148
20. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981; 48: 2742-2745
21. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-1233
22. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343: 71-74
23. Ransohoff DF. Colon cancer in ulcerative colitis. Gastroenterology 1988; 94: 1089-1091
24. Jain SK, Peppercorn MA. Inflammatory bowel disease and colon cancer - a review. Digestive Diseases 1997; 15: 243-252
25. Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granqvist S. Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scan J Gastroenterol 1996; 31: 1195-1204
26. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis (see comments). Gastroenterology 1994; 107: 934-944
27. Dyck WP, Cloud ML, Offen WW, Matsumoto C, Chernish SM. Treatment of duodenal ulceration in the United States. Scand J Gastroenterol Suppl 1987; 136: 47-55
28. Melville DM, Jass JR, Morson BC, Pollock DJ, Richman PI, Shepherd NA, Ritchie JK, Love SB, Lennard-Jones JE. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 1989; 20: 1008-1014
29. Dixon MF, Brown LJ, Gilmour HM, Price AB, Smeeton NC, Talbot IC, Williams GT. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988; 13: 385-397
30. Korelitz BI. Considerations of surveillance, dysplasia, and carcinoma of the colon in the management of ulcerative colitis and Crohn's disease. Med Clin North Am 1990; 74: 189-199
31. Lennard-Jones JE. Is colonoscopic cancer surveillance in ulcerative colitis essential for every patient? Eur J Cancer 1995; 31: 1178-1182
32. Collins RH Jr, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987; 316: 1654-1658
33. Axon AT. Colonic cancer surveillance in ulcerative colitis is not essential for every patient? Eur J Cancer 1995; 31: 1183-1186
34. Lennard-Jones JE. Cancer risk in ulcerative colitis: surveillance or surgery. Br J Surg 1985; 72: S84-S86
35. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993; 105: 418-424
36. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990; 99: 1021-1031
37. Lashner BA. Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single university-based surveillance program. Am J Gastroenterol 1992; 87: 168-175
38. Fuson JA, Farmer RG, Hawk A, Sullivan BH. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol 1980; 73: 120-126
39. Matiushichev VB, Soldatov AI. High energy laser irradiation in the combined treatment of duodenal ulcer. Klin Med Mosk 1994; 72: 15-16
40. Martin LF. Stress ulcers are common after aortic surgery. Endoscopic evaluation of prophylactic therapy. American Surgeon 1994; 60: 169-174
41. Rozen P, Baratz M, Fefer F, Gilat T. Low incidence of significant dyplasia in a successful endoscopic surveillance program of patients with ulcerative colitis (see comments). Gastroenterology 1995; 108: 1361-1370
42. Jonsson B, Ahsgren L, Andersson LO, Stenling R, Rutegard J. Colorectal cancer surveillance in patients with ulcerative colitis. British Journal of Surgery 1994; 81: 689-691
43. Lynch DA, Lobo AJ, Sobala GM, Dixon MF, Axon AT. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993; 34: 1075-1080
44. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-359
45. Richards ME, Rickert RR, Nance FC. Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Annals of Surgery 1989; 209: 764-773
46. Craft CF, Mendelsohn G, Cooper HS, Yardley JH. Colonic "precancer" in Crohn's disease. Gastroenterology 1981; 80: 578-584
47. Hamilton SR. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology 1985; 89: 398-407